Stock Detail
SCICLONE PHARMACEUTICALS INC
Drug Manufacturers Other
SCLN @ Yahoo Finance | SCLN Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $4.46 | $4.56 | $-0.02 | -0.45% | 0.00 | $4.48 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $4.42 | $4.41 | 137,256 | 260.87M | 260,873.5 | 12.43 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 4.63 | 4.55 | 4.48 | 4.40 | 4.33 |
Stock Profile
SciClone Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutics to treat life-threatening diseases. Its products include ZADAXIN is in phase 3 hepatitis C virus clinical trials, as well as in other late-stage clinical trials for the treatment of hepatitis B virus and certain cancers. The company also develops SCV-07, which is in preclinical studies, for the treatment of viral and other infectious diseases. The company sells its products primarily in Asia, the Middle East, and Latin America. SciClone Pharmaceuticals was founded in 1989 and is headquartered in San Mateo, California.